INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStromâ„¢ in RDEB

Go back to INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStromâ„¢ in RDEB
(NASDAQ: INMB) Delayed: 2.44 +0.17 (7.49%)
Previous Close $2.27    52 Week High
Open $2.27    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.22    EPS
Volume 323,962       

(NASDAQ: INMB) Delayed: 2.44 +0.17 (7.49%)
Previous Close $2.27    52 Week High
Open $2.27    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.22    EPS
Volume 323,962